CN209392577U - A kind of minimally invasive elevator belt of face - Google Patents
A kind of minimally invasive elevator belt of face Download PDFInfo
- Publication number
- CN209392577U CN209392577U CN201820701477.6U CN201820701477U CN209392577U CN 209392577 U CN209392577 U CN 209392577U CN 201820701477 U CN201820701477 U CN 201820701477U CN 209392577 U CN209392577 U CN 209392577U
- Authority
- CN
- China
- Prior art keywords
- protrusion
- minimally invasive
- poly
- elevator belt
- face
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Materials For Medical Uses (AREA)
Abstract
The utility model provides a kind of minimally invasive elevator belt of face, including having the elongated straps body of thickness, multiple connecting holes is distributed on the one side with body, multiple protrusions for being pierced into facial fascia superficialis system are distributed on another side.The utility model provides a kind of simple, easy to use, good fixing effect the minimally invasive elevator belt of face of structure, and compared with prior art, the utility model solves the clinical problem for staying the end of a thread and be not fixed firmly after current hangnail line suspention.
Description
Technical field
The utility model relates to a kind of plastic operation materials, and in particular to a kind of minimally invasive elevator belt of face.
Background technique
With advancing age, face appearance relaxes, is sagging, and specific manifestation goes out tissue recess, tissue moves down accumulation, elasticity
The clinical symptoms such as reduction, wrinkle increase.It is a kind of common medical hand in beautifying face plastic operation that face crinkle-removing, which promotes operation,
Then art arrive nonabsorable material from traditional Tossed Mung Clear Noodles in Sauce operation to the promotion art of mini-invasive incision, then arrive PDO, PPDO,
PLLA etc. can be a quantum leap of medical cosmetology technology by the material implantation that body tissue is metabolized, and it is small, extensive that technology possesses wound
It answers advantages, the clinics such as fast, effect duration is long, can be implanted into repeatedly and is able to extensive utilization.But mini-invasive incision, which promotes art, is
Various suspention lines are implanted between the skin and muscle of face by minimally invasive method, to the relative position of facial muscles and skin
It is adjusted, to achieve the purpose that wrinkle removal beauty treatment, although wound is small, the guidance needle due to burying suspention line at present is straight
Needle, therefore the suspention line being embedded between skin and muscle is also linearly to be distributed, so the position of suspention is single point, is drawn
Position be also it is local, cannot achieve the purpose that integrally to improve, overall effect is unobvious.
For this purpose, clinic is highly desirable to a kind of better implantation instrument of minimally invasive fixed effect and method.
Utility model content
The technical problem to be solved by the present invention is to provide a kind of minimally invasive elevator belt of face, structure is simple, it is easy to use,
Good fixing effect, the clinical problem for staying the end of a thread and be not fixed firmly after solving current hangnail line suspention.
In order to solve the above technical problems, the embodiments of the present invention provide a kind of minimally invasive elevator belt of face, including tool thickness
The elongated straps body of degree is distributed with multiple connecting holes on the one side with body, multiple piercing faces is distributed on another side
The protrusion of portion's fascia superficialis system.
Wherein, the connecting hole is through the through-hole with body.
Further, the structure snd size of each protrusion with side side are identical, and it is described protrusion have can be inserted into through-hole
And the structure snd size with through-hole close-fitting.
The structure snd size of the protrusion with side side can also be different, multiple protrusions point with side side described at this time
For the first bonding pad protrusion and the first lifting zone protrusion, first bonding pad protrusion have can be inserted into through-hole and with through-hole close-fitting
Structure snd size.
Wherein, the connecting hole with one side of body is blind hole.
If the blind hole is overlapped in the axial direction with the protrusion with another side of body, at this point, if the depth of the blind hole
Greater than the thickness with body, the structure snd size of the protrusion with side side cannot be all identical, then described with side side
Protrusion be divided into the second bonding pad protrusion and the second lifting zone protrusion, second bonding pad protrusion have can be inserted into blind hole and with it is blind
The structure snd size of hole close-fitting.If the depth of the blind hole is less than the thickness with body, the structure of the protrusion with side side
Also cannot be all identical with size, the protrusion with side side is divided into third bonding pad protrusion and third lifting zone protrusion,
Third bonding pad protrusion have can be inserted into blind hole and the structure snd size with blind hole close-fitting.
If the blind hole is not overlapped in the axial direction with the protrusion with another side of body.At this point, if the depth of the blind hole
Degree is greater than the thickness with body, and the structure snd size of each protrusion with side side can be identical, and the protrusion has and can insert
Enter blind hole and the structure snd size with blind hole close-fitting.The structure snd size of each protrusion with side side can not also all phases
Together, the protrusion with side side described at this time is divided into the 4th bonding pad protrusion and the 4th lifting zone protrusion, and the 4th bonding pad is convex
It rises to have and can be inserted into blind hole and the structure snd size with blind hole close-fitting.
If the depth of the blind hole is less than the thickness with body, the structure snd size of each protrusion with side side cannot
All identical, the protrusion with side side described at this time is divided into the 5th bonding pad protrusion and the 5th lifting zone protrusion, the 5th connection
Area's protrusion have can be inserted into blind hole and the structure snd size with blind hole close-fitting.
Wherein, the lower end outside of the protrusion is equipped with hangnail.
Wherein, the width with body is 0.01mm-100mm, with a thickness of 0.01mm-10mm.
Preferably, the width with body is 0. 1mm-10mm, with a thickness of 0.05mm-3mm.
Wherein, the material for preparing with body is degradable biomaterial.
Preferably, the degradable biomaterial includes the high molecular material of biological source and abiotic source, wherein
The high molecular material of the biological source include: collagen and its derivative, cellulose and its derivates, chitosan and its
Derivative, hyaluronic acid and its derivative；
The high molecular material in the abiotic source includes: polylactic acid, degradable medical polyurethane, polycaprolactone, gathers to two
Oxa- cyclohexanone and its copolymer (PPDO, PLA-PDO) it is poly- to dioxa cyclohexanone (PPDO), polytrimethylene carbonate,
Polylactic acid-trimethylene carbonate copolymer, polycaprolactone-trimethylene carbonate copolymer, polyglycolic acid, poly- cream
Acid-co-glycolic acid, polyether-ether-ketone, polyvinylpyrrolidone and/or polyethylene glycol, poly- valerolactone, in poly- ε-last of the ten Heavenly stems
Ester, polyactide, polyglycolide, polyactide and the copolymer of polyglycolide, poly- ε-caprolactone, polyhydroxybutyrate, poly- hydroxyl fourth
Acid esters, poly- hydroxyl valerate, poly butyric ester-copolymerization-valerate, poly- (Isosorbide-5-Nitrae-dioxane -2,3- diketone),
Poly- (1,3- dioxane -2- ketone), poly-p-dioxanone, polyanhydride (such as poly-maleic anhydride), poly- hydroxyl
Methyl acrylate, fibrin, polybutylcyanoacrylate, polycaprolactone dimethylacrylate, poly- β-maleic two
Acid, polycaprolactone butyl propyleneglycol acid esters, more block polymerizations from oligomerization caprolactone diol and oligomerization dioxanone glycol
Object, polyethylene glycol and polybutylene terephthalate)), poly- pivalolactone, polyglycolic acid carbonate, polycaprolactone-
Glycolide, poly- (DTH- iminocarbonic ester), poly- (DTE- copolymerization-DT- carbonic ester), gathers poly- (γ-ethyl glutamate)
(bisphenol-A-iminocarbonic ester), polyorthoester, polyglycolic acid carbonate, poly- trimethyl carbonate, poly- imino group carbon
Acid esters, polyvinyl alcohol, polyesteramide, dealing with alcohol polyester, polyphosphate, polyphosphazene, gathers poly- (N- vinyl)-pyrrolidones
[to carboxyphenoxy) propane], poly- hydroxypentanoic acid, polyanhydride, polyethylene glycol oxide-propylene oxide, flexibel polyurethane, in main chain
Polyurethane, polyether ester (such as polyethylene glycol oxide), polyalkylene oxalate, polyorthoester with amino acid residue and it is total
Polymers, fibrinogen, starch, collagen, contains protein polymer, polyaminoacid, synthesis polyaminoacid, jade at carrageenan
One of rice gluten, the viscosity average molecular weigh of the biodegradable high molecular material is 500~1000000.
Wherein the material of degradable medical polyurethane is selected from polyether-type, polyester-polyether type, natural polymer subtype and plant
The biodegradable PU of oil type, aliphatic poly ether urethane, polyurethane-acrylate hydrogel, fatty poly-ester carbonate urethane,
Polyurethane-urea elastomers, polyurethane-polydimethylsiloxaneblock block copolymers, one of polyether thermoplastic polyurethane or
Two kinds, specifically include the polyurethane that hard section is done with lysine diisocyanate, soft segment can be with polyalcohol, polyethylene glycol 200,
One of polyethylene glycol 400, Macrogol 600 or it is a variety of be initiator, one of LA, GA, CL, PDO, adipic anhydride or
A variety of to obtain polymer diol, chain extension selecting is chosen in particular from ethylene glycol, two from chain extender diol or diamine or class diamine
Glycol, tetraethylene glycol, 1,3- propylene glycol, Isosorbide-5-Nitrae-butanediol, 1,6- hexylene glycol, 1,7- heptandiol, 1,8- ethohexadiol, 1,9-
One or both of nonanediol, 1,10- decanediol, ethylenediamine, propane diamine, butanediamine, pentanediamine, class diamine.
The more preferable soft segment raw material of medical polyurethane diaphragm is selected from one of polyurethane, polyester, polyethers, polyaminoacid
Or two kinds of combinations, it is chosen in particular from poly- valerolactone, poly- ε-decalactone, polylactide, polyglycolide, polylactide and polyglycolide
Copolymer, polylactide-co-glycolide copolymer, poly- 6-caprolactone, polyhydroxybutyrate, poly butyric ester, poly- hydroxyl penta
Acid esters, poly butyric ester -co- valerate, poly- (Isosorbide-5-Nitrae-dioxanes -2,3- diketone), poly- (1,3- dioxanes -2- ketone), poly-
P-dioxanone, polyanhydride, polymaleic anhydride, poly- hydroxyl-metacrylate, fibrin, polybutylcyanoacrylate,
Polycaprolactone propylene dimethyl phthalate, poly- β-maleic acid, polycaprolactone butyl acrylate, by castor oil, the poly- hydroxyl of microbial fermentation
Base butyric acid valerate (PHBV) and chemically synthesized polyvinyl alcohol (PVA), the bio-based polyurethane material of preparation, more block polymerizations
Object is such as: from oligomerization caprolactone diol, oligomerization dioxanone glycol, polyether ester multi-block polymer, poly- pivalolactone,
Polyglycolic acid trimethyl carbonate, polycaprolactone-glycolide, poly- (g- ethyl glutamate), polyglycine, polyalanine, poly- figured silk fabrics ammonia
Sour, poly- leucine, poly- isoleucine, polyphenylalanine and polyproline, poly- tryptophan, polyserine, polytyrosine, poly- half Guang
Propylhomoserin, poly- methionine, poly-asparagine, polyglutamine and poly- threonine, poly-aspartate and polyglutamic acid, polylysine,
Poly arginine and polyhistidyl or be different aminoacids polymer polypeptide, preferably with free amine group by basic amino acid
Such as one or both of poly arginine, polylysine and the polyhistidyl combination being polymerized.
More preferable polylactic acid, polycaprolactone, is gathered to dioxa cyclohexanone and its copolymer degradable medical polyurethane
(PPDO, PLA-PDO) is poly- to dioxa cyclohexanone (PPDO), polytrimethylene carbonate, polylactic acid-trimethylene carbonate
Copolymer, polycaprolactone-trimethylene carbonate copolymer, polyglycolic acid, one in polylactic acid-co-glycolic acid
Kind, one or more of PLLA, PLA, PGA, PDO and PCL.
Polypeptide that is commercially available or having disclosed, albumen and active constituent can be added in polyurethane material, including
Antiproliferative, anti-migration, anti-angiogenesis, anti-inflammatory, anti-inflammatory, cell growth inhibition, cytotoxicity antithrombotic have
The drug of physiological activity.
Hydrophilic material can also be added, carbomer, Polycarbophil, Sodium Hyaluronate, sodium alginate, poly- ammonia are specifically included
Base acid, polypeptide, povidone, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, hydroxyethyl cellulose, sodium carboxymethyl starch, poly- second
Enol, xanthan gum, modified alginates and its it is degraded into the alginate of aminohexose and N- acetylglucosamine, starch
Grafted propylene nitrile, starch-grafted hydrophilic monomer, polyacrylate, vinyl acetate co-polymer, modified poly ethylene alcohols, fibre
Tie up plain grafted propylene nitrile, cellulose graft acrylates, cellulose xanthogenation grafted propylene hydrochlorate, cellulose graft acryloyl
Epoxychloropropane intersects one of crosslinking or multiple combinations after amine, carboxymethyl cellulose.
Wherein, the material for preparing with body is non-degradable biomaterial.
Preferably, the non-degradable material is the mixing of one or more of titanium, gold, silver and nickel.
Wherein, it is described with body preparing material be degradable biomaterial in addition promote collagen growth various growths because
Son or the drug for the treatment of aging.
The utility model also provides a kind of moulding process of minimally invasive elevator belt of face, is one of following moulding process:
The first: being placed in 3D printer for face minimally invasive elevator belt biomaterial, then depict in 3D printer
The structure of the designed minimally invasive elevator belt of face, directly prints；
Second: being placed in designed mold, be molded after the minimally invasive elevator belt of face is melted with biomaterial；
The third: being made flat wire with biomaterial for the minimally invasive elevator belt of face, suppressed by grinding tool
4th kind: band is made after the minimally invasive elevator belt of face is melted with biomaterial, passes through numerically-controlled machine tool or laser essence
It is close to be process；
5th kind: the minimally invasive elevator belt of face being dissolved or dispersed in organic solvent with biomaterial, colloidal sol is made, is placed in
Die for molding forms.
The utility model also provides a kind of working method of minimally invasive elevator belt of face, includes the following steps:
(1) it will wherein a minimally invasive elevator belt of face be placed in puncture needle, be implanted by puncture needle along hair line；
(2) two minimally invasive elevator belts of face separately are taken, by the shallow muscle below the minimally invasive elevator belt implantation cheek of wherein a face
The protrusion indentation tissue of the remote hairline line end of the minimally invasive elevator belt of face is promptly integrally held skin by morphology, will be apart from hair
In the connecting hole for the minimally invasive elevator belt of face that protrusion indentation step (1) of border line proximal end has been implanted into；It mentions another face is minimally invasive
It rises in band implantation Face and cheek musculature, by the protrusion indentation tissue of the remote hairline line end of the minimally invasive elevator belt of face, integrally holds skin
Skin will realize in the connecting hole apart from the minimally invasive elevator belt of face that protrusion indentation step (1) of hair line proximal end has been implanted into
The effect of face lift.
The utility model also provides a kind of purposes of minimally invasive elevator belt of face, and for face lift, buttocks is promoted or human body
Any position for needing shaping to be promoted.
The above-mentioned technical proposal of the utility model has the beneficial effect that: the utility model provide a kind of structure it is simple,
The minimally invasive elevator belt of face easy to use, good fixing effect, compared with prior art, the utility model solves current hangnail
The clinical problem for staying the end of a thread and be not fixed firmly after line suspention.
Detailed description of the invention
Fig. 1 is the main view of the utility model embodiment one；
Fig. 2 is the top view of embodiment one；
Fig. 3 is the main view of the utility model embodiment two；
Fig. 4 is the top view of embodiment two；
Fig. 5 is the main view of the utility model embodiment three；
Fig. 6 is the main view of the utility model embodiment four；
Fig. 7 is the main view of the utility model embodiment five；
Fig. 8 is the main view of the utility model embodiment six；
Fig. 9 is the main view of the utility model embodiment seven；
Figure 10 is state diagram one when the utility model is used；
Figure 11 is state diagram two when the utility model is used；
Figure 12 is state diagram three when the utility model is used；
Figure 13 is state diagram four when the utility model is used；
Figure 14 is the structure of the utility model protrusions.
Description of symbols:
1, band body；100, connecting hole；101, raised；2, the first bonding pad protrusion；3, the first lifting zone protrusion；4, second connects
Connect area's protrusion；5, the second lifting zone protrusion；6, third bonding pad protrusion；7, third lifting zone protrusion；8, the 4th bonding pad protrusion；
9, the 4th lifting zone protrusion；10, the 5th bonding pad protrusion；11, the 5th lifting zone protrusion.
Specific embodiment
In order to make the technical problems, technical solutions and advantages to be solved by the utility model clearer, below in conjunction with attached drawing
And specific embodiment is described in detail.
Embodiment 1
As shown in Figure 1 and Figure 2, the embodiments of the present invention provide a kind of minimally invasive elevator belt of face, including having the length of thickness
Multiple connecting holes 100 are distributed on the one side with body 1 in striped belt body 1, and multiple piercings faces are distributed on another side
The protrusion 101 of fascia superficialis system.
In the present embodiment, the connecting hole 100 is through the through-hole with body.
Each raised 101 structure snd size with 1 side of body are identical, and described raised 101 have can be inserted into through-hole
And the structure snd size with through-hole close-fitting.
Embodiment 2
As shown in Figure 3, Figure 4, the structure of the structure with embodiment 1 of the present embodiment is essentially identical, and difference is: the band body
The structure of multiple protrusions of side is not exactly the same, and multiple protrusions are divided into the first bonding pad protrusion 2 and the first lifting zone protrusion 3,
First bonding pad protrusion 2 has and can be inserted into through-hole and the structure snd size with through-hole close-fitting.Structure based on the present embodiment,
The size relative to the first lifting zone protrusion 3 that the size of first bonding pad protrusion 2 can be done is small.
Embodiment 3
As shown in figure 5, the connecting hole with one side of body is blind hole.The blind hole exists with the protrusion with another side of body
It is overlapped in axial direction.
In the present embodiment, the depth of the blind hole is greater than the thickness with body, and the protrusion with side side is divided into the second company
Connect area's protrusion 4 and the second lifting zone protrusion 5, the second bonding pad protrusion 4 has and can be inserted into blind hole and the knot with blind hole close-fitting
Structure and size.Size of the size of second bonding pad protrusion 4 less than the second lifting zone protrusion 5.
Embodiment 4
As shown in fig. 6, the connecting hole with one side of body is blind hole.The blind hole exists with the protrusion with another side of body
It is overlapped in axial direction.
In the present embodiment, the depth of the blind hole is less than the thickness with body, and the protrusion with side side is divided into third company
Connect area's protrusion 6 and third lifting zone protrusion 7, the third bonding pad protrusion 6 has and can be inserted into blind hole and the knot with blind hole close-fitting
Structure and size.The size of third bonding pad protrusion 6 is much smaller than the size of third lifting zone protrusion 7.
Embodiment 5
As shown in fig. 7, the blind hole is not overlapped in the axial direction with the protrusion with another side of body.
In the present embodiment, the depth of the blind hole is greater than the thickness with body, the structure of each protrusion with side side with
Size is identical, and it is described protrusion have can be inserted into blind hole and the structure snd size with blind hole close-fitting.
Embodiment 6
As shown in figure 8, the blind hole is not overlapped in the axial direction with the protrusion with another side of body.
In the present embodiment, the depth of the blind hole is greater than the thickness with body, and the protrusion with side side is divided into the 4th company
Connect area's protrusion 8 and the 4th lifting zone protrusion 9, the 4th bonding pad protrusion 8 has and can be inserted into blind hole and the knot with blind hole close-fitting
Structure and size.Size of the size of 4th bonding pad protrusion 8 less than the 4th lifting zone protrusion 9.
Embodiment 7
As shown in figure 9, the blind hole is not overlapped in the axial direction with the protrusion with another side of body.
In the present embodiment, the depth of the blind hole is less than the thickness with body, and the protrusion with side side is divided into the 5th company
Connect area's protrusion 10 and the 5th lifting zone protrusion 11, the 5th bonding pad protrusion 10 have can be inserted into blind hole and with blind hole close-fitting
Structure snd size.
Hangnail can be set in the lower end outside of protrusion in the various embodiments described above, can be using such as Figure 14 (a)-(h) institute
The structure shown.
In the utility model, the width with body is 0.01mm-100mm, with a thickness of 0.01mm-10mm.It is preferred that described
Width with body is 0. 1mm-10mm, with a thickness of 0.05mm-3mm.
The material for preparing with body in the utility model is degradable biomaterial, or non-degradable biology material
Material.
If degradable biomaterial, the high molecular material including biological source and abiotic source, wherein
The high molecular material of the biological source include: collagen and its derivative, cellulose and its derivates, chitosan and its
Derivative, hyaluronic acid and its derivative；
The high molecular material in the abiotic source includes: polylactic acid, degradable medical polyurethane, polycaprolactone, gathers to two
Oxa- cyclohexanone and its copolymer (PPDO, PLA-PDO) it is poly- to dioxa cyclohexanone (PPDO), polytrimethylene carbonate,
Polylactic acid-trimethylene carbonate copolymer, polycaprolactone-trimethylene carbonate copolymer, polyglycolic acid, poly- cream
Acid-co-glycolic acid, polyether-ether-ketone, polyvinylpyrrolidone and/or polyethylene glycol, poly- valerolactone, in poly- ε-last of the ten Heavenly stems
Ester, polyactide, polyglycolide, polyactide and the copolymer of polyglycolide, poly- ε-caprolactone, polyhydroxybutyrate, poly- hydroxyl fourth
Acid esters, poly- hydroxyl valerate, poly butyric ester-copolymerization-valerate, poly- (Isosorbide-5-Nitrae-dioxane -2,3- diketone),
Poly- (1,3- dioxane -2- ketone), poly-p-dioxanone, polyanhydride (such as poly-maleic anhydride), poly- hydroxyl
Methyl acrylate, fibrin, polybutylcyanoacrylate, polycaprolactone dimethylacrylate, poly- β-maleic two
Acid, polycaprolactone butyl propyleneglycol acid esters, more block polymerizations from oligomerization caprolactone diol and oligomerization dioxanone glycol
Object, polyethylene glycol and polybutylene terephthalate)), poly- pivalolactone, polyglycolic acid carbonate, polycaprolactone-
Glycolide, poly- (DTH- iminocarbonic ester), poly- (DTE- copolymerization-DT- carbonic ester), gathers poly- (γ-ethyl glutamate)
(bisphenol-A-iminocarbonic ester), polyorthoester, polyglycolic acid carbonate, poly- trimethyl carbonate, poly- imino group carbon
Acid esters, polyvinyl alcohol, polyesteramide, dealing with alcohol polyester, polyphosphate, polyphosphazene, gathers poly- (N- vinyl)-pyrrolidones
[to carboxyphenoxy) propane], poly- hydroxypentanoic acid, polyanhydride, polyethylene glycol oxide-propylene oxide, flexibel polyurethane, in main chain
Polyurethane, polyether ester (such as polyethylene glycol oxide), polyalkylene oxalate, polyorthoester with amino acid residue and it is total
Polymers, fibrinogen, starch, collagen, contains protein polymer, polyaminoacid, synthesis polyaminoacid, jade at carrageenan
One of rice gluten, the viscosity average molecular weigh of the biodegradable high molecular material is 500~1000000.
Wherein the material of degradable medical polyurethane is selected from polyether-type, polyester-polyether type, natural polymer subtype and plant
The biodegradable PU of oil type, aliphatic poly ether urethane, polyurethane-acrylate hydrogel, fatty poly-ester carbonate urethane,
Polyurethane-urea elastomers, polyurethane-polydimethylsiloxaneblock block copolymers, one of polyether thermoplastic polyurethane or
Two kinds, specifically include the polyurethane that hard section is done with lysine diisocyanate, soft segment can be with polyalcohol, polyethylene glycol 200,
One of polyethylene glycol 400, Macrogol 600 or it is a variety of be initiator, one of LA, GA, CL, PDO, adipic anhydride or
A variety of to obtain polymer diol, chain extension selecting is chosen in particular from ethylene glycol, two from chain extender diol or diamine or class diamine
Glycol, tetraethylene glycol, 1,3- propylene glycol, Isosorbide-5-Nitrae-butanediol, 1,6- hexylene glycol, 1,7- heptandiol, 1,8- ethohexadiol, 1,9-
One or both of nonanediol, 1,10- decanediol, ethylenediamine, propane diamine, butanediamine, pentanediamine, class diamine.
The more preferable soft segment raw material of medical polyurethane diaphragm is selected from one of polyurethane, polyester, polyethers, polyaminoacid
Or two kinds of combinations, it is chosen in particular from poly- valerolactone, poly- ε-decalactone, polylactide, polyglycolide, polylactide and polyglycolide
Copolymer, polylactide-co-glycolide copolymer, poly- 6-caprolactone, polyhydroxybutyrate, poly butyric ester, poly- hydroxyl penta
Acid esters, poly butyric ester -co- valerate, poly- (Isosorbide-5-Nitrae-dioxanes -2,3- diketone), poly- (1,3- dioxanes -2- ketone), poly-
P-dioxanone, polyanhydride, polymaleic anhydride, poly- hydroxyl-metacrylate, fibrin, polybutylcyanoacrylate,
Polycaprolactone propylene dimethyl phthalate, poly- β-maleic acid, polycaprolactone butyl acrylate, by castor oil, the poly- hydroxyl of microbial fermentation
Base butyric acid valerate (PHBV) and chemically synthesized polyvinyl alcohol (PVA), the bio-based polyurethane material of preparation, more block polymerizations
Object is such as: from oligomerization caprolactone diol, oligomerization dioxanone glycol, polyether ester multi-block polymer, poly- pivalolactone,
Polyglycolic acid trimethyl carbonate, polycaprolactone-glycolide, poly- (g- ethyl glutamate), polyglycine, polyalanine, poly- figured silk fabrics ammonia
Sour, poly- leucine, poly- isoleucine, polyphenylalanine and polyproline, poly- tryptophan, polyserine, polytyrosine, poly- half Guang
Propylhomoserin, poly- methionine, poly-asparagine, polyglutamine and poly- threonine, poly-aspartate and polyglutamic acid, polylysine,
Poly arginine and polyhistidyl or be different aminoacids polymer polypeptide, preferably with free amine group by basic amino acid
Such as one or both of poly arginine, polylysine and the polyhistidyl combination being polymerized.
More preferable polylactic acid, polycaprolactone, is gathered to dioxa cyclohexanone and its copolymer degradable medical polyurethane
(PPDO, PLA-PDO) is poly- to dioxa cyclohexanone (PPDO), polytrimethylene carbonate, polylactic acid-trimethylene carbonate
Copolymer, polycaprolactone-trimethylene carbonate copolymer, polyglycolic acid, one in polylactic acid-co-glycolic acid
Kind, one or more of PLLA, PLA, PGA, PDO and PCL.
Polypeptide that is commercially available or having disclosed, albumen and active constituent can be added in polyurethane material, including
Antiproliferative, anti-migration, anti-angiogenesis, anti-inflammatory, anti-inflammatory, cell growth inhibition, cytotoxicity antithrombotic have
The drug of physiological activity.
Hydrophilic material can also be added, carbomer, Polycarbophil, Sodium Hyaluronate, sodium alginate, poly- ammonia are specifically included
Base acid, polypeptide, povidone, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, hydroxyethyl cellulose, sodium carboxymethyl starch, poly- second
Enol, xanthan gum, modified alginates and its it is degraded into the alginate of aminohexose and N- acetylglucosamine, starch
Grafted propylene nitrile, starch-grafted hydrophilic monomer, polyacrylate, vinyl acetate co-polymer, modified poly ethylene alcohols, fibre
Tie up plain grafted propylene nitrile, cellulose graft acrylates, cellulose xanthogenation grafted propylene hydrochlorate, cellulose graft acryloyl
Epoxychloropropane intersects one of crosslinking or multiple combinations after amine, carboxymethyl cellulose.
It can be titanium, gold, silver, nickel etc. if non-degradable biomaterial.
In the utility model, the material for preparing with body is that addition promotes each of collagen growth in degradable biomaterial
Kind growth factor or the drug for treating aging.
The utility model also provides a kind of moulding process of minimally invasive elevator belt of face, is one of following moulding process:
The first: being placed in 3D printer for face minimally invasive elevator belt biomaterial, then depict in 3D printer
The structure of the designed minimally invasive elevator belt of face, degradable biomaterial is melted, by design structure printing shaping；
Second: being placed in designed mold, be molded after the minimally invasive elevator belt of face is melted with biomaterial；
The third: being made flat wire with biomaterial for the minimally invasive elevator belt of face, suppressed by grinding tool
4th kind: banded structure is made after the minimally invasive elevator belt of face is melted with biomaterial, by numerically-controlled machine tool or
Laser precision machining forms；
5th kind: the minimally invasive elevator belt of face being dissolved or dispersed in organic solvent with biomaterial, colloidal sol is made, is placed in
Die for molding forms.
The utility model also provides a kind of working method of minimally invasive elevator belt of face, includes the following steps:
(1) it will wherein a minimally invasive elevator belt of face be placed in puncture needle, be implanted by puncture needle along hair line；
(2) two minimally invasive elevator belts of face separately are taken, by the shallow muscle below the minimally invasive elevator belt implantation cheek of wherein a face
The protrusion indentation tissue of the remote hairline line end of the minimally invasive elevator belt of face is promptly integrally held skin by morphology, will be apart from hair
In the connecting hole for the minimally invasive elevator belt of face that protrusion indentation step (1) of border line proximal end has been implanted into；It mentions another face is minimally invasive
It rises in band implantation Face and cheek musculature, by the protrusion indentation tissue of the remote hairline line end of the minimally invasive elevator belt of face, integrally holds skin
Skin will realize in the connecting hole apart from the minimally invasive elevator belt of face that protrusion indentation step (1) of hair line proximal end has been implanted into
The effect of face lift.Various status diagrams when face lift are as shown in Figure 10 ~ Figure 13.
The utility model also provides a kind of purposes of minimally invasive elevator belt of face, and for face lift, buttocks is promoted or human body
Any position for needing shaping to be promoted.
The effect of the utility model is further illustrated below by experiment under implantation pigskin.
It is implanted into Germicidal efficacy under pigskin
By using the minimally invasive elevator belt of face of second and the preparation of the third moulding process, oxirane disinfection is used.Selection 6
The pig of weight 20KG or so, implantation is subcutaneously observed respectively, and every group 3.The swelling journey of postoperative routine observation subcutaneous location
Degree, serology, histotomy observation.The results showed that the latter all inner skins of elevator belt implantation are locally general red, occur slight
Inflammatory reaction, inflammatory reaction disappears after two weeks, and after implantation 4 weeks, lift belt stimulates surrounding tissue fibroplasia, initially forms packet
Film, histocompatbility are fine.
The above descriptions are merely preferred embodiments of the present invention, not makees in any form to the utility model
Limitation, any person skilled in the art do not departing within the scope of technical solutions of the utility model, when using above-mentioned
The technology contents of announcement make a little change or the equivalent embodiment for being modified to equivalent variations, but all without departing from the utility model
The content of technical solution, any simple modification, equally change made by the above technical examples according to the technical essence of the present invention
Change and modify, is still within the scope of the technical solutions of the present invention.
Claims (10)
1. a kind of minimally invasive elevator belt of face, which is characterized in that including having the elongated straps body of thickness, on the one side with body
Multiple connecting holes are distributed with, multiple protrusions for being pierced into facial fascia superficialis system are distributed on another side.
2. the minimally invasive elevator belt of face according to claim 1, which is characterized in that the connecting hole is through logical with body
Hole.
3. the minimally invasive elevator belt of face according to claim 2, which is characterized in that the structure of each protrusion with side side
It is identical with size, and the protrusion has the structure snd size that can be inserted into through-hole.
4. the minimally invasive elevator belt of face according to claim 1, which is characterized in that the connecting hole with one side of body is blind
Hole.
5. the minimally invasive elevator belt of face according to claim 4, which is characterized in that the blind hole with the convex of another side of body
It rises and is overlapped in the axial direction.
6. the minimally invasive elevator belt of face according to claim 5, which is characterized in that the depth of the blind hole is less than the thickness with body
Degree, the protrusion with side side are divided into third bonding pad protrusion and third lifting zone protrusion, third bonding pad protrusion tool
There are the structure snd size that can be inserted into blind hole.
7. the minimally invasive elevator belt of face according to claim 4, which is characterized in that the blind hole with the convex of another side of body
It rises and is not overlapped in the axial direction.
8. the minimally invasive elevator belt of face according to claim 7, which is characterized in that the depth of the blind hole is greater than the thickness with body
Degree, the structure snd size of each protrusion with side side are identical, and the protrusion has the structure snd size that can be inserted into blind hole.
9. the minimally invasive elevator belt of face according to claim 7, which is characterized in that the depth of the blind hole is greater than the thickness with body
Degree, the protrusion with side side are divided into the 4th bonding pad protrusion and the 4th lifting zone protrusion, the 4th bonding pad protrusion tool
There are the structure snd size that can be inserted into blind hole.
10. according to claim 1, the minimally invasive elevator belt of face described in any one of 3,4,6 ~ 9, which is characterized in that the protrusion
Lower end outside be equipped with hangnail, the width with body be 0.01mm-100mm, with a thickness of 0.01mm-10mm.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201820701477.6U CN209392577U (en) | 2018-05-11 | 2018-05-11 | A kind of minimally invasive elevator belt of face |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201820701477.6U CN209392577U (en) | 2018-05-11 | 2018-05-11 | A kind of minimally invasive elevator belt of face |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN209392577U true CN209392577U (en) | 2019-09-17 |
Family
ID=67876693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201820701477.6U Active CN209392577U (en) | 2018-05-11 | 2018-05-11 | A kind of minimally invasive elevator belt of face |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN209392577U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108742945A (en) * | 2018-05-11 | 2018-11-06 | 圆容生物医药无锡有限公司 | A kind of minimally invasive elevator belt of face, its moulding process and its working method |
-
2018
- 2018-05-11 CN CN201820701477.6U patent/CN209392577U/en active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108742945A (en) * | 2018-05-11 | 2018-11-06 | 圆容生物医药无锡有限公司 | A kind of minimally invasive elevator belt of face, its moulding process and its working method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10722445B2 (en) | Biphasic compositions for tissue augmentation | |
| CN108350619B (en) | Suture thread and method for producing same | |
| Kudur et al. | Sutures and suturing techniques in skin closure | |
| CA2363262C (en) | Bioabsorbable, biocompatible polymers for tissue engineering | |
| CA2263361A1 (en) | Implant for subcutaneous or intradermal injection | |
| US20060058892A1 (en) | Valved tissue augmentation implant | |
| GB0202233D0 (en) | Bioresorbable polymers | |
| CN108392667A (en) | Desalination scar medical dressing with tissue inducing function and preparation method thereof | |
| MX2007002987A (en) | Tissue augmentation device. | |
| CN1151859A (en) | One-way suture retaining device for braided sutures | |
| WO2008072229A2 (en) | Methods for dermal filling using microneedles | |
| CN108888798A (en) | A kind of flexible foldable biomembrane and preparation method thereof | |
| US20080248079A1 (en) | Tissue augmentation devices and methods | |
| CN209392577U (en) | A kind of minimally invasive elevator belt of face | |
| EP1114839A4 (en) | Polyester diol, polyurethane obtained therefrom and spandex filament thereof, and novel dialkylamino-containing acrylic copolymer, polyurethane composition, and spandex composition | |
| CN104448479A (en) | Medical antibacterial agent modified LDPE and preparation method thereof | |
| CN110787319A (en) | Implant for facial cosmetic lifting and application thereof | |
| US20040267315A1 (en) | Braided gold suture and method of use | |
| KR20210137513A (en) | Sutures, suture devices and their applications | |
| Nahabedian | Nipple reconstruction | |
| CN108742945A (en) | A kind of minimally invasive elevator belt of face, its moulding process and its working method | |
| US20060058890A1 (en) | Methods for soft tissue augmentation | |
| RU2135122C1 (en) | Method for producing skin rejuvenascence | |
| CN201436996U (en) | Absorbable medical wrinkle-removing pad film | |
| KR102378824B1 (en) | Biodegradable polymeric thread filler for promoting the formation of collagen in skin and method for preparing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CP03 | Change of name, title or address | ||
| CP03 | Change of name, title or address |
Address after: Workshop 601-3, 6th Floor, Jinhong Industrial Park (Workshop I), No. 72, Jinhong 4th Road, Tangjiawan Town, High tech Zone, Zhuhai City, Guangdong Province, 519000 Patentee after: Zhuhai Aohua Fuwei Medical Technology Co.,Ltd. Address before: 2/F, Building C, Airport Industrial Park, No. 35 Changjiang South Road, Wuxi City, Jiangsu Province, 214142 Patentee before: YUANRONG BIOLOGICAL PHARMACEUTICAL Co.,Ltd. WUXI |